Oncology Clinical Development Expertise

Our experienced teams have helped clients with more than 400 Oncology studies for solid tumors, hematologic malignancies and diagnostic imaging tools.  Additionally, we’ve worked on over 30 US and European regulatory submission projects for cancer treatments, including many rare cancers.

Oncology Experience

With cancer being the second* leading cause of death today, it’s no wonder that Veristat’s clients are prioritizing their pipelines to develop life-extending cancer therapies. 

Veristat's teams work on a spectrum of amazing cancer treatments including drugs, vaccines, and diagnostics.

  • Cancer clinical development comprises 40% of the work we do
  • Cancer treatments account for 46% of the submission projects we've worked on
  • In the past 5 years, 10 oncology products were approved for NDAs and jNDAs that we prepared

*Source: http://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm


Contact Veristat Now

Request A Proposal

Contact Us

Experience in Solid Tumors & Blood Cancers

From bladder to thyroid cancers Veristat is well-equipped to support your next solid tumor trial. Review the table below to see our full range of experience in this oncology category.

Veristat also has expansive experience in blood cancers. Whether malignant or non-malignant we have you covered. 

Click here to learn more about all of our hematology experience.


Customized Oncology Solutions

Our solutions span the entire clinical development life-cycle - and are offered as a comprehensive, all-inclusive solution or as functional support. We offer strategic guidance for informed decision-making, operational support to mitigate trial risks, the statistical knowledge to prove safety and efficacy, the medical oversight to ensure patient safety, and the regulatory expertise to achieve approval success.


Solutions Span Early to Late Phase



Learn More with These Resources

Case Study
Medical Writing Partnership - IND to NDA

Learn how the Veristat medical writing team partnered with a sponsor and supported their entire rare oncology program from IND to NDA.

FDA Expedited Pathways

View the infographic to learn how to leverage FDA’s expedited pathways to accelerate product development. We outline the requirements, benefits, and procedures for ...

Webinar Presentation
Leveraging FDA Expedited Programs for Product Development

View the webinar presentation to learn about the requirements, benefits, timing, and procedures for securing Fast Track Designation (FT), Breakthrough Therapy ...

Request A Proposal